Gaudium IVF and Women Health Limited will commence commercial operations at its newly built IVF Centre in South Extension Part-II, New Delhi, on July 16, 2026. Funded through its February 2026 IPO, the state-of-the-art clinical hub will offer advanced embryology laboratories and specialized reproductive care.
NEW DELHI, India — Gaudium IVF and Women Health Limited has announced that it will officially commence commercial operations at its brand-new, state-of-the-art IVF Centre and Hub in South Extension, New Delhi, starting July 16, 2026.
This strategic expansion marks a significant milestone for the healthcare provider as it scales its specialized reproductive services to meet the growing demand for world-class fertility care in the national capital region. Equipped with cutting-edge medical infrastructure and modern embryology laboratories, the new center is poised to serve patients seeking highly precise, compassionate, and advanced fertility treatments.
Expanding Clinical Footprint in South Delhi
The launch of the Gaudium IVF - South Extension Centre represents the company's commitment to delivering accessible, premium fertility and reproductive healthcare services. Strategically located on the First Floor, M-1, South Extension Part-II, New Delhi-110049, the newly built facility is designed to offer a comprehensive range of clinical services.
The establishment of this clinical hub directly aligns with the corporate growth objectives outlined in the company's Initial Public Offer (IPO) prospectus dated February 25, 2026. By utilizing capital generated from public markets to establish regional hubs, Gaudium IVF is actively expanding its operational footprint to offer advanced fertility treatments to a broader demographic.
State-of-the-Art Embryology Infrastructure
The newly commissioned South Extension hub is designed around a patient-centric care model supported by high-specification reproductive technologies. According to company regulatory filings, the center will house advanced embryology laboratories to ensure optimal environmental controls for delicate embryo culture and selection.
Patients visiting the center will have access to a complete spectrum of reproductive healthcare services, including:
Advanced In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) cycles.
Pre-implantation Genetic Testing (PGT) to screen for chromosomal abnormalities.
Cryopreservation facilities for vitrification of eggs, sperm, and embryos.
Comprehensive diagnostics and corrective reproductive surgeries managed by a team of highly experienced fertility specialists and embryologists.
The integration of these diagnostic and therapeutic capabilities under one roof ensures streamlined patient journeys and optimized clinical outcomes.
Impact on Patients, Families, and Investors
The launch of the Gaudium IVF - South Extension Centre has significant positive implications across multiple stakeholder groups:
For Patients & Families: Residents of South Delhi and neighboring regions will gain local access to a highly specialized reproductive clinical hub. This eliminates the need for long-distance travel to receive specialized IVF procedures, bringing premium clinical services closer to home.
For the Healthcare Sector: The center's focus on advanced embryology standards raises the benchmark for clinical reproductive sciences in northern India.
For Shareholders & Investors: The successful commencement of operations demonstrates Gaudium IVF's strong execution capability in utilizing IPO proceeds precisely as committed in its public prospectus. This timely execution is expected to bolster investor confidence in the stock exchange listings.
Official Sources Section
The official announcement of the commercial launch was made via a regulatory disclosure submitted on July 15, 2026, to both the BSE Limited (Scrip Code: 544709) and the National Stock Exchange of India Limited (Symbol: GAUDIUMIVF).
The corporate filing was executed under Regulation 30 and Para B of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026. The document was formally signed and authorized by Naveen Kumar, the Company Secretary and Compliance Officer of Gaudium IVF and Women Health Limited.
Quote Section
According to the official regulatory statement released by the company's compliance department:
"In compliance with Regulation 30 read with Para B of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that, in line with the objects of the Initial Public Offer of the Company, as mentioned in the Prospectus dated February 25, 2026, the Company will commence operations at the Company’s new IVF Centre/Hub at South Extension, New Delhi with effect from July 16, 2026."
Why It Matters
In reproductive medicine, success rates are heavily influenced by laboratory quality and medical expertise. By introducing advanced embryology laboratories to South Delhi, Gaudium IVF is elevating local standards of care. Additionally, from a business perspective, completing this facility in accordance with the timelines set out in its February 2026 IPO prospectus shows strong corporate governance and execution capabilities, driving long-term enterprise value.
Key Facts at a Glance
Milestone Launch: Gaudium IVF is opening its newest premium facility in South Extension, New Delhi.
Operational Date: Commercial operations are scheduled to officially commence on July 16, 2026.
Precise Location: The center is situated at First Floor, M-1, South Extension Part-II, New Delhi-110049.
Key Services: Specialized IVF, advanced embryology services, and holistic reproductive healthcare.
Strategic Financing: Funded directly through the proceeds of the company's Initial Public Offer (IPO) completed in February 2026.
FAQ Section
What services will the new South Extension centre offer?
The facility is fully equipped to provide complete In Vitro Fertilization (IVF) treatments, diagnostic assessments, advanced embryology services, and comprehensive reproductive healthcare.
Where is the new Gaudium IVF centre located?
The clinical hub is situated at First Floor, M-1, South Extension Part-II, New Delhi-110049.
How was the development of this new clinic funded?
The construction and establishment of the South Extension hub were financed using the capital raised during the company's Initial Public Offer (IPO) on February 25, 2026.
Sources: Gaudium IVF and Women Health Limited Investor Relations Portal, Company Disclosure to Stock Exchanges
